CIK 0000313143 · Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- operating
- EIN
- 042882273
- Phone
- 7818487100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $101,148
- in 1 filing
Net −$101,148. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Option exercise | +1,068 | $89.16 | $95K | 7,310 |
| 2026-11-11 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Option exercise | +645 | $95.73 | $62K | 7,955 |
| 2026-11-11 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Option exercise | +433 | $70.31 | $30K | 8,388 |
| 2026-11-11 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Shares withheld for taxes | −1,724 | $121.10 | $209K | 6,664 |
| 2026-11-11 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Sale | −836 | $120.99 | $101K | 5,828 |
| 2026-11-11 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Option exercise · Non-qualified Stock Option (Right to Buy) | −1,068 | 357 | ||
| 2026-11-11 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Option exercise · Non-qualified Stock Option (Right to Buy) | −645 | 646 | ||
| 2026-11-11 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Option exercise · Non-qualified Stock Option (Right to Buy) | −433 | 1,299 | ||
| 2026-10-30 | Galvin Roy EVP, Chief Commercial Officer | Shares withheld for taxes | −146 | $119.65 | $17K | 39,805 |
| 2026-07-24 | Madaus Martin D Director | Grant or award | +2,538 | 2,538 | ||
| 2026-07-24 | Zane Ellen M Director | Grant or award | +2,538 | 21,911 | ||
| 2026-07-24 | Pomeroy Claire Director | Grant or award | +2,538 | 19,410 | ||
| 2026-07-24 | KROLL MARK W Director | Grant or award | +2,538 | 27,295 | ||
| 2026-07-24 | Johnson Lloyd Emerson Director | Grant or award | +2,538 | 15,471 | ||
| 2026-07-24 | COYLE MICHAEL J Director | Grant or award | +2,538 | 17,932 | ||
| 2026-07-24 | Bryant Diane M Director | Grant or award | +2,538 | 9,664 | ||
| 2026-07-24 | ABERNATHY ROBERT E Director | Grant or award | +2,538 | 27,519 | ||
| 2026-06-05 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Shares withheld for taxes | −259 | $71.28 | $18K | 6,242 |
| 2026-06-05 | Miller Laurie A. SVP, Human Resources | Shares withheld for taxes | −313 | $71.28 | $22K | 40,987 |
| 2026-05-15 | Basil Michelle L EVP and General Counsel | Shares withheld for taxes | −2,913 | $56.29 | $164K | 40,405 |
Page 1 of 25 · 493 trades